dr. armstrong on the utility of ar-v7 as a biomarker in prostate cancer
Published 4 years ago • 80 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:26
dr. armstrong on ar-v7 as a biomarker of response to taxane chemotherapy in mcrpc
-
1:01
dr. armstrong discusses ar-v7 testing in prostate cancer
-
6:30
ar-v7 as a predictive marker in prostate cancer
-
7:46
prostate cancer: validation of ar-v7 testing
-
6:14
androgen receptor splice variant, ar-v7, as prostate cancer biomarker
-
3:22
detection of ar-v7 in prostate cancer
-
0:42
dr. rathkopf on ar-v7 biomarker in prostate cancer
-
3:04
prostate cancer: educating physicians about ar-v7 testing
-
1:00
dr. armstrong on the utility of pamiparib and other parp inhibitors in prostate cancer
-
4:10
practical implications of ar-v7 testing in prostate
-
0:57
dr. armstrong on the utility of parp inhibitors in mutated prostate cancer
-
4:19
the biology of prostate cancer
-
5:34
multidisciplinary care for prostate cancer and ar-v7 status
-
1:40
dr. armstrong on detection of chromosomal defects in mcrpc
-
6:29
ar-v7 and drug resistance
-
0:56
dr. armstrong on sipuleucel-t in prostate cancer
-
9:12
prostate cancer: epic sciences ar-v7 test
-
3:36
john’s hopkins ar-v7 test in prostate
-
1:18
dr. armstrong discusses arches trial in prostate cancer